loratadine has been researched along with Weight Gain in 2 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Astemizole-treated patients showed statistically significantly more weight gain than did loratadine-treated patients." | 2.67 | Once daily loratadine versus astemizole once daily. ( Banov, C; Boggs, P; Chervinsky, P; Georgitis, J; Greenstein, S; Vande Souwe, R, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gasheva, OY | 1 |
| Tsoy Nizamutdinova, I | 1 |
| Hargrove, L | 1 |
| Gobbell, C | 1 |
| Troyanova-Wood, M | 1 |
| Alpini, SF | 1 |
| Pal, S | 1 |
| Du, C | 1 |
| Hitt, AR | 1 |
| Yakovlev, VV | 1 |
| Newell-Rogers, MK | 1 |
| Zawieja, DC | 1 |
| Meininger, CJ | 1 |
| Alpini, GD | 1 |
| Francis, H | 1 |
| Gashev, AA | 1 |
| Chervinsky, P | 1 |
| Georgitis, J | 1 |
| Banov, C | 1 |
| Boggs, P | 1 |
| Vande Souwe, R | 1 |
| Greenstein, S | 1 |
1 trial available for loratadine and Weight Gain
| Article | Year |
|---|---|
Once daily loratadine versus astemizole once daily.
Topics: Administration, Oral; Adolescent; Adult; Astemizole; Child; Dose-Response Relationship, Drug; Double | 1994 |
1 other study available for loratadine and Weight Gain
| Article | Year |
|---|---|
Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome.
Topics: Adipose Tissue; Animals; Fatty Liver; Insulin Resistance; Lipids; Loratadine; Lymphatic Vessels; Mal | 2019 |